These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 14555703)

  • 21. SU5416 inhibited VEGF and HIF-1alpha expression through the PI3K/AKT/p70S6K1 signaling pathway.
    Zhong XS; Zheng JZ; Reed E; Jiang BH
    Biochem Biophys Res Commun; 2004 Nov; 324(2):471-80. PubMed ID: 15474452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of connective tissue growth factor on hypoxia-inducible factor 1alpha degradation and tumor angiogenesis.
    Chang CC; Lin MT; Lin BR; Jeng YM; Chen ST; Chu CY; Chen RJ; Chang KJ; Yang PC; Kuo ML
    J Natl Cancer Inst; 2006 Jul; 98(14):984-95. PubMed ID: 16849681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of the mammary carcinoma angiogenic switch in C3(1)/SV40 transgenic mice by a mutated form of human endostatin.
    Calvo A; Yokoyama Y; Smith LE; Ali I; Shih SC; Feldman AL; Libutti SK; Sundaram R; Green JE
    Int J Cancer; 2002 Sep; 101(3):224-34. PubMed ID: 12209972
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stemness marker ALDH1A1 promotes tumor angiogenesis via retinoic acid/HIF-1α/VEGF signalling in MCF-7 breast cancer cells.
    Ciccone V; Terzuoli E; Donnini S; Giachetti A; Morbidelli L; Ziche M
    J Exp Clin Cancer Res; 2018 Dec; 37(1):311. PubMed ID: 30541574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peroxiredoxin 1 stimulates endothelial cell expression of VEGF via TLR4 dependent activation of HIF-1α.
    Riddell JR; Maier P; Sass SN; Moser MT; Foster BA; Gollnick SO
    PLoS One; 2012; 7(11):e50394. PubMed ID: 23185615
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aloe-emodin suppresses hypoxia-induced retinal angiogenesis
    Wu J; Ke X; Wang W; Zhang H; Ma N; Fu W; Zhao M; Gao X; Hao X; Zhang Z
    Int J Biol Sci; 2016; 12(11):1363-1371. PubMed ID: 27877088
    [No Abstract]   [Full Text] [Related]  

  • 27. Pseudolaric acid B inhibits angiogenesis and reduces hypoxia-inducible factor 1alpha by promoting proteasome-mediated degradation.
    Li MH; Miao ZH; Tan WF; Yue JM; Zhang C; Lin LP; Zhang XW; Ding J
    Clin Cancer Res; 2004 Dec; 10(24):8266-74. PubMed ID: 15623602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A radicicol derivative, KF58333, inhibits expression of hypoxia-inducible factor-1alpha and vascular endothelial growth factor, angiogenesis and growth of human breast cancer xenografts.
    Kurebayashi J; Otsuki T; Kurosumi M; Soga S; Akinaga S; Sonoo H
    Jpn J Cancer Res; 2001 Dec; 92(12):1342-51. PubMed ID: 11749701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Androgens stimulate hypoxia-inducible factor 1 activation via autocrine loop of tyrosine kinase receptor/phosphatidylinositol 3'-kinase/protein kinase B in prostate cancer cells.
    Mabjeesh NJ; Willard MT; Frederickson CE; Zhong H; Simons JW
    Clin Cancer Res; 2003 Jul; 9(7):2416-25. PubMed ID: 12855613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of the pro-angiogenic microenvironment by carboxyamido-triazole.
    Oliver VK; Patton AM; Desai S; Lorang D; Libutti SK; Kohn EC
    J Cell Physiol; 2003 Oct; 197(1):139-48. PubMed ID: 12942550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Wogonin inhibits tumor angiogenesis via degradation of HIF-1α protein.
    Song X; Yao J; Wang F; Zhou M; Zhou Y; Wang H; Wei L; Zhao L; Li Z; Lu N; Guo Q
    Toxicol Appl Pharmacol; 2013 Sep; 271(2):144-55. PubMed ID: 23707765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of geldanamycin on HIF-1alpha mediated angiogenesis and invasion in prostate cancer cells.
    Alqawi O; Moghaddas M; Singh G
    Prostate Cancer Prostatic Dis; 2006; 9(2):126-35. PubMed ID: 16432534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reactive oxygen species regulate insulin-induced VEGF and HIF-1alpha expression through the activation of p70S6K1 in human prostate cancer cells.
    Zhou Q; Liu LZ; Fu B; Hu X; Shi X; Fang J; Jiang BH
    Carcinogenesis; 2007 Jan; 28(1):28-37. PubMed ID: 16774940
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Jianpi Jiedu decoction, a traditional Chinese medicine formula, inhibits tumorigenesis, metastasis, and angiogenesis through the mTOR/HIF-1α/VEGF pathway.
    Peng W; Zhang S; Zhang Z; Xu P; Mao D; Huang S; Chen B; Zhang C; Zhang S
    J Ethnopharmacol; 2018 Oct; 224():140-148. PubMed ID: 29852266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conjugation of gold nanoparticles and recombinant human endostatin modulates vascular normalization via interruption of anterior gradient 2-mediated angiogenesis.
    Pan F; Yang W; Li W; Yang XY; Liu S; Li X; Zhao X; Ding H; Qin L; Pan Y
    Tumour Biol; 2017 Jul; 39(7):1010428317708547. PubMed ID: 28714365
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of antiangiogenic effect using 99mTc-EC-endostatin.
    Yang DJ; Kim KD; Schechter NR; Yu DF; Wu P; Azhdarinia A; Roach JS; Kalimi SK; Ozaki K; Fogler WE; Bryant JL; Herbst R; Abbruzzes J; Kim EE; Podoloff DA
    Cancer Biother Radiopharm; 2002 Apr; 17(2):233-45. PubMed ID: 12030117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypoxia-inducible factor 1alpha modulates adhesion, migration, and FAK phosphorylation in vascular smooth muscle cells.
    Corley KM; Taylor CJ; Lilly B
    J Cell Biochem; 2005 Dec; 96(5):971-85. PubMed ID: 16149050
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclooxygenase-2 increases hypoxia-inducible factor-1 and vascular endothelial growth factor to promote angiogenesis in gastric carcinoma.
    Huang SP; Wu MS; Shun CT; Wang HP; Hsieh CY; Kuo ML; Lin JT
    J Biomed Sci; 2005; 12(1):229-41. PubMed ID: 15864753
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quinacrine inhibits HIF-1α/VEGF-A mediated angiogenesis by disrupting the interaction between cMET and ABCG2 in patient-derived breast cancer stem cells.
    Das B; Dash SR; Patel H; Sinha S; Bhal S; Paul S; Das C; Pradhan R; Ahmed I; Goutam K; Kundu CN
    Phytomedicine; 2023 Aug; 117():154914. PubMed ID: 37321076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
    Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
    Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.